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Protein Kinase C-bII Represses Hepatocyte Growth
Factor-Induced Invasion by Preventing the
Association of Adapter Protein Gab1 and
Phosphatidylinositol 3-Kinase in Melanoma Cells
Masahiro Oka1, Ushio Kikkawa2 and Chikako Nishigori1
The hepatocyte growth factor (HGF) signaling pathway was examined in human normal melanocytes and three
malignant melanoma cell lines. HGF-induced activation of c-Met, its receptor-tyrosine kinase, was observed in
both melanocytes and melanoma cells, whereas phosphatidylinositol 3-kinase (PI3K), a downstream target of
c-Met, was not activated in the melanocytes but enhanced in the melanoma cell lines. The electrophoretic
mobility of Gab1, the scaffolding adapter protein that couples activated c-Met and PI3K, was slower in the
melanocytes than that in the melanoma cells, and the mobility shifted to that of the melanoma cells after
treatment with alkaline phosphatase, indicating that Gab1 is highly phosphorylated on serine and threonine in
the melanocytes. Introduction of protein kinase C (PKC)-bII into the melanoma cells, which is expressed in
melanocytes but absent in melanoma cells, resulted in serine and threonine phosphorylation of Gab1 and also
prevented tyrosine phosphorylation of Gab1 and its association with PI3K. Furthermore, the introduction of
PKC-bII suppressed HGF-induced activation of PI3K, and attenuated the in vitro invasion activity of the
melanoma cells. These results indicate that the HGF signaling process from Gab1 to PI3K is negatively regulated
by PKC-bII, and its loss is critical for melanoma cells to gain invasive potential.
Journal of Investigative Dermatology (2008) 128, 188–195; doi:10.1038/sj.jid.5700961; published online 12 July 2007
INTRODUCTION
Hepatocyte growth factor (HGF), also known as scatter factor,
has mitogenic, motogenic, and morphogenic activity through
its tyrosine kinase-receptor c-Met in various types of cells
(Trusolino and Comoglio, 2002; Birchmeier et al., 2003).
c-Met transmits intercellular signals using the multisubstrate-
docking site present in its C-terminal end region. Stimulation
causes phosphorylation of two tyrosine residues in the
multisubstrate-docking site, Tyr-1356 and -1349, which
mediates the binding of the adapter proteins Grb2 and
Gab1, respectively (Guy et al., 2002; Gu and Neel, 2003).
These adapter proteins in turn recruit several proteins to form
signaling complexes. Grb2 couples with Son of Sevenless
(SOS) to activate Ras and its downstream signaling pathway
including extracellular signal-regulated kinase (ERK)/mitogen-
activated protein kinase (MAPK). Gab1 associates with class I
phosphatidylinositol 3-kinase (PI3K) consisting of the adapter
subunit (p85) and the catalytic subunit (p110), directly or
through Grb2, to enhance the lipid kinase reaction. An
aberrant increase in PI3K products is frequently observed in
transformed cells (Toker and Cantley, 1997; Katso et al.,
2001), and it has been proposed that the HGF/c-Met signaling
pathway plays a critical role in the tumor progression of
melanoma (Natali et al., 1993; Hendrix et al., 1998).
Transgenic mice ubiquitously expressing HGF spontaneously
develop melanomas with a high invasive and metastatic
potential (Takayama et al., 1997; Otsuka et al., 1998), and the
HGF signaling pathway has been studied in normal melano-
cytes and melanoma cells (Halaban et al., 1992). However,
the role and regulation of PI3K as the downstream target of c-
Met has not been analyzed in these cells in detail.
Protein kinase C (PKC) is a protein-serine/threonine kinase,
which is activated by diacylglycerol generated by receptor-
coupled hydrolysis of phosphoinositides, and is the major
intracellular receptor for tumor-promoting phorbol esters
(Nishizuka, 1995). PKC is a family consisting of nine genes in
mammals including a, b, g, d, e, Z, y, z, and l, and two
splicing variants, bI and bII, are derived from the b-gene
(Coussens et al., 1987; Ono et al., 1987). The PKC isoforms
have distinct properties and show differential distribution in
ORIGINAL ARTICLE
188 Journal of Investigative Dermatology (2008), Volume 128 & 2007 The Society for Investigative Dermatology
Received 27 January 2007; revised 2 April 2007; accepted 17 April 2007;
published online 12 July 2007
1Division of Dermatology, Department of Clinical Molecular Medicine, Kobe
University Graduate School of Medicine, Kobe, Japan and 2Biosignal
Research Center, Kobe University, Kobe, Japan
Correspondence: Dr Masahiro Oka, Division of Dermatology, Department of
Clinical Molecular Medicine, Kobe University Graduate School of Medicine,
7-5-1, Kusonoki-cho, Chuo-ku, Kobe 650-0017, Japan.
E-mail: oka@med.kobe-u.ac.jp
Abbreviations: ERK, extracellular signal-regulated kinase; HGF, hepatocyte
growth factor; PI3K, phosphatidylinositol 3-kinase; PKC, protein kinase C;
SOS, son of sevenless
tissues and cells, and many studies have been carried out to
clarify the role of each isoform in the physiological and
pathological responses of the cells. We have analyzed
previously the expression of the PKC isoforms in cultured
human normal melanocytes and human melanoma cell lines
by biochemical study and immunoblot analysis (Oka et al.,
1996). Melanocytes and melanoma cells commonly
expressed a, d, e, and z isoforms. In addition, the bII isoform
(PKC-bII) was found in melanocytes, but was not detected in
most melanoma cell lines such as MeWo, HM3KO, and
HMV-I. This expression profile of PKC-bII has also been
observed in many other melanoma cell lines (Yamanishi
et al., 1991; Gilhooly et al., 2001; Krasagakis et al., 2002;
Oka and Kikkawa, 2005) and melanoma cells in vivo (Oka
et al., 2006).
In this study, the HGF/c-Met signaling pathway was
compared in human normal melanocytes and melanoma
cell lines, and the results showed that PKC-bII regulates the
coupling of Gab1 with PI3K, which induces invasion in the
melanoma cells.
RESULTS
HGF-induced activation of c-Met
As an initial step in the study of the HGF/c-Met signaling
pathway in melanocytes and melanoma cells, the response of
c-Met to HGF in normal melanocytes and the melanoma cell
lines MeWo, HM3KO, and HMV-I was examined. c-Met,
immunoprecipitated from both melanocytes and melanoma
cells, was revealed to be phosphorylated on tyrosine within
5 minutes after the HGF treatment as determined by
immunoblot analysis using an anti-phosphotyrosine antibody
(Figure 1). c-Met is, therefore, activated by HGF in both
melanocytes and melanoma cells, and these results are
consistent with those of a previous report (Halaban et al.,
1992).
Activation of PI3K and ERK
Next, the activity of PI3K and ERK, two major targets of
c-Met, was analyzed. HGF did not activate PI3K in melano-
cytes during the period of observation even at high
concentrations, but clearly enhanced the lipid kinase reaction
in the three melanoma cell lines (Figure 2a and b). Thus, the
effect of insulin, which induces PI3K activation in various
cells, was investigated (Toker and Cantley, 1997; Katso et al.,
2001), and insulin was revealed to enhance PI3K activity
markedly in melanocytes (Figure 2a). These results indicate
that PI3K was operating in the insulin-signaling pathway, but
was not activated by HGF in melanocytes. The effects of
HGF varied among the melanoma cell lines, but the lipid
kinase was clearly activated in a time- and dose-dependent
manner (Figure 2b). In contrast to PI3K, ERK was activated by
HGF in melanocytes as judged by immunoblot analysis using
an antibody specific for activated ERK (Figure 3). In
melanoma cells, ERK was constitutively activated even under
resting conditions, as reported previously (Satyamoorthy
et al., 2003). After HGF stimulation, the amounts of
phosphorylated ERK increased further, albeit slightly, in
MeWo cells, and HGF showed similar effects on ERK in
HM3KO and HMV-I cells. Therefore, HGF regulates ERK
activity in both normal melanocytes and melanoma cells,
whereas it activates PI3K only in the latter cells, suggesting an
inhibitory mechanism for the signaling route from c-Met to
PI3K in melanocytes.
Electrophoretic mobility of Gab1
The scaffolding adapter protein Gab1, that is recruited to
activated c-Met either directly or through Grb2 and interacts
with the p85 subunit of PI3K (Gu and Neel, 2003), was
analyzed as a candidate responsible for the different PI3K
signaling processes in melanocytes and melanoma cells
(Figure 4). Gab1 recovered from the three melanoma cell
lines migrated as an approximately 105K protein band,
whereas the adapter protein isolated from melanocytes
appeared as a broad band with an approximate molecular
size of around 120K on SDS-PAGE (Figure 4, upper left
panel). The electrophoretic mobility of Gab1 recovered from
melanocytes shifted to that of melanoma cells after treatment
with alkaline phosphatase in vitro, and the amount of the
adapter protein was similar in the melanocytes and melanoma
cell lines (Figure 4, upper middle and right panels). These
results indicate that Gab1 is heavily phosphorylated in
melanocytes. Next, the melanoma cell line MeWo was
infected with an adenovirus vector carrying PKC-bII, that is
expressed in melanocytes but not in melanoma cells
(Yamanishi et al., 1991; Oka et al., 1996; Gilhooly et al.,
2001; Krasagakis et al., 2002). Gab1 showed a slower
electrophoretic mobility in the melanoma cells expressing
PKC-bII as in melanocytes, and the mobility returned to the
level of the control cells expressing LacZ after alkaline
phosphatase treatment (Figure 4, lower panels). The protein
kinase activity of PKC-bII is required to shift Gab1, because
the introduction of its kinase-negative mutant (KN-PKCb) did
not affect the mobility of the protein. Infection of the
adenovirus vector carrying PKC-a, which has the structure
closely related to that of PKC-bII and is endogenously
expressed in the melanoma cell line (Nishizuka, 1995) had
no effect either. Similar results were obtained in HM3KO and
HMV-I cells (data not shown). Therefore, Gab1 appears to be
phosphorylated under the control of PKC-bII.
IP: PY20
IB: c-Met
Melanocytes
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Figure 1. HGF-induced activation of c-Met in melanocytes and melanoma
cells. The cells were treated with 100 ng/ml HGF for the indicated time. Cell
lysates were immunoprecipitated (IP) with anti-phosphotyrosine antibody
PY20 followed by immunoblot (IB) analysis using the anti-c-Met antibody.
The results are representative of three independent experiments.
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Association of GAB1 and PI3K
It is well known that Gab1 is phosphorylated on tyrosine and
associates with the p85 subunit of PI3K through its SH2
domain (Gu and Neel, 2003). Therefore, the interaction of
Gab1 and PI3K was examined in HGF-treated melanoma
cells (Figure 5a). In MeWo cells infected with the control
virus, the association of the p85 subunit of PI3K with Gab1,
which are both expressed endogenously, was detected on
stimulation with HGF. The introduction of PKC-bII into the
melanoma cells prevented HGF-induced binding of PI3K to
the adapter protein. Next, the effect of the introduction of
PKC-bII on tyrosine phosphorylation of Gab1 was analyzed
(Figure 5b). In control cells, Gab1 was slightly phosphory-
lated under resting conditions and treatment with HGF
enhanced phosphorylation on tyrosine. The introduction of
PKC-bII blocked HGF-induced tyrosine phosphorylation of
Gab1, which is consistent with the results of the association
of PI3K with Gab1. Effects of HGF stimulation on the
association of Gab1 with the p85 subunit of PI3K were
examined also in melanocytes (Figure 5a). As expected, HGF-
induced association of Gab1 with the p85 was not observed
in melanocytes.
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Figure 2. Activation of PI3K in melanocytes and melanoma cells. (a) Melanocytes were treated with either 100 ng/ml HGF (left panels) or with 5 mg/ml
insulin (right panels) for the indicated time. The immunoprecipitates with PY20 from cell lysates were assayed for PI3K activity. (b) Melanocytes and melanoma
cells were treated with 100 ng/ml HGF for the indicated time (upper panel) or treated with various concentrations of HGF for 5 minutes (lower panel). The
relative radioactivities of PI(3)P are expressed as a percentage of that in untreated control cells, and data are shown as means7SD from three independent
experiments.
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Figure 3. Activation of ERK in melanocytes and melanoma cells. The cells
were treated with 100 ng/ml HGF for the indicated time. Cell lysates were
subjected to immunoblot analysis using anti-phospho-ERK and anti-ERK
antibodies, respectively. The results shown are representative of three
independent experiments.
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Figure 4. The electrophoretic mobility of Gab1. Gab1 immunoprecipitated
from melanocytes and melanoma cells was subjected to immunoblot analysis
using an antibody against Gab1 (upper panels). MeWo cells were infected
with each adenovirus vector, and the immunoprecipitated Gab1 and cell
lysates were subjected to immunoblot analysis using anti-Gab1 anti-PKC
antibodies, respectively (lower panels). Where indicated, the
immunoprecipitates were treated with calf intestine alkaline phosphatase
in vitro. Open and closed arrows indicate the position of Gab1. The results
shown are representative of three independent experiments.
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Role of PKC-bII in both the regulation of PI3K and invasion
activity
Finally, the effects of introducing PKC-bII on both HGF-
induced PI3K activation and the invasive potential of three
melanoma cell lines were examined (Figure 6). The
dominant-negative mutant of PI3K (Dp85), which prevents
PI3K activation on cell stimulation by competing with the
authentic p85 subunit (Toker and Cantley, 1997; Katso et al.,
2001), was employed as a positive control. The introduction
of PKC-bII into MeWo cells attenuated both the HGF-induced
activation of PI3K and cell invasion as in the cells infected
with the virus vector of Dp85. PKC-a was inert, as in the
regulation of Gab1. Essentially, the same results were
Melano-
cytes
AxPKC AxPKC
AxLacZ
IP: Gab1a b IP: Gab1
Gab1Gab1
Gab1
Gab1
p85
p85
p85
IB: IB:
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Figure 5. Association of the p85 subunit of PI3K and Gab1 in MeWo cells
but not melanocytes. MeWo cells infected with either AxPKC-b or AxLacZ
and melanocytes were serum-starved and treated with 100 ng/ml HGF for the
indicated time. (a) Gab1 in MeWo cells (upper and middle panels) and in
melanocytes (lower panel) was immunoprecipitated from cell lysates and
subjected to immunoblot analysis using anti-Gab1 and anti-p85 subunit,
respectively. (b) Gab1 in MeWo cells was immunoprecipitated from cell
lysates and subjected to immunoblot analysis using anti-Gab1 and PY20
antibodies, respectively. The results shown are representative of three
independent experiments.
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Figure 6. PI3K activation and invasive activity of melanoma cells. The cells were infected with each adenovirus vector and serum-starved. PI3K activity was
measured after treatment with 100 ng/ml HGF for 5 minutes, and is expressed as a percentage of that in untreated cells (upper panels). Data are shown as
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Figure 7. HGF-induced signaling pathways in the melanocytes and
melanoma cells. The regulatory mechanisms revealed in this study are
schematically presented.
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obtained in HM3KO and HMV-I cells, indicating that PKC-bII
specifically prevents HGF-enhanced invasive potential
through inhibition of PI3K activity in the melanoma cell lines.
DISCUSSION
We found that HGF activates PI3K in melanoma cells, but not
in normal melanocytes. Then, we focused on Gab1, the
scaffolding adapter protein that couples c-Met to the p85
subunit of PI3K (Gu and Neel, 2003). Gab1 was highly
phosphorylated in melanocytes as determined by electro-
phoretic mobility and acid phosphatase treatment, whereas
this adapter protein was less phosphorylated in melanoma
cell lines. Gual et al. (2001) have reported that okadaic acid,
a potent inhibitor of protein-serine/threonine phosphatases
such as PP1 and PP2A, induces hyperphosphorylation of
Gab1 on serine and threonine residues in mouse liver
progenitor MLP29 cells. Therefore, Gab1 seems to be
phosphorylated at multiple sites by a number of protein-
serine/threonine kinases. In fact, HGF induces phosphoryla-
tion at Thr-477 of Gab1 by ERK in mIMCD-3 epithelial cells
accompanying the enhanced association of PI3K with this
adapter protein (Yu et al., 2001). ERK also phosphorylates
Gab1 on serine/threonine residues other than Thr-477 in
epidermal growth factor-stimulated cells (Yu et al., 2002).
However, ERK is probably not responsible for the Gab1
phosphorylation selectively observed in melanocytes in this
study, because ERK was constitutively activated in melanoma
cells. In addition, activation of Rho kinase causes Gab1
phosphorylation in the breast tumor cell line MDA-MB-231
(Bourguignon et al., 2003), and studies using PKC inhibitors
and antisense oligonucleotides have suggested that PKC
regulates Gab1 in erythroid progenitor cells (von Lindern
et al., 2000), Caco-2 colon cancer cells (Kermorgant et al.,
2001), and vascular smooth muscle cells (Saito et al., 2002).
In the case of PKC, PKC-a and PKC-b1 phosphorylate Gab1 in
vitro, and the expression of the active form of these two
isoforms induces phosphorylation of the adapter protein in
transfected COS-7 cells (Gual et al., 2001). Different
nomenclatures have been employed, but PKC-b1 (Coussens
et al., 1987) corresponds to PKC-bII (Ono et al., 1987). We
found that the introduction of PKC-bII into melanoma cells,
which is expressed in normal melanocytes but not in the
cancer cells (Yamanishi et al., 1991; Oka et al., 1996;
Gilhooly et al., 2001; Krasagakis et al., 2002), induces
hyperphosphorylation of Gab1. The catalytic activity of PKC-
bII was essential, and overexpression of PKC-a did not
regulate Gab1 in melanoma cells. Taken together, Gab1
seems to be phosphorylated by a series of protein-serine/
threonine kinases at multiple sites, and PK-CbII has a critical
role in the negative regulation of Gab1 in normal melano-
cytes as well as in melanoma cells by phosphorylating the
adapter protein directly or through other protein kinases.
Practically, Gab1 has 116 serine and threonine residues that
are conserved among different mammalian species such as
human (Holgado-Madruga et al., 1996), mouse (Weidner
et al., 1996), and hamster (Kameda et al., 2001), which
contain 694, 695, and 694 amino-acid residues, respectively.
Analysis of the phosphorylation sites will be helpful for the
identification of the protein kinases involved in the regulation
of Gab1.
The introduction of PKC-bII into melanoma cells inhibited
the HGF-induced tyrosine phosphorylation of Gab1 and the
association of Gab1 with p85 (Figure 5). Presumably,
phosphorylation of Gab1 on serine and threonine residues
by PKC-bII blocks its HGF-induced tyrosine phosphorylation
and subsequent coupling with PI3K. As expected, the
melanoma cells expressing PKC-bII showed attenuated PI3K
and cell invasion activity in response to HGF. These results
are compatible with those for the regulation of cell scattering
and branching tubulogenesis in MLP29 cells (Gual et al.,
2001) and cell migration in HepG2 hepatoma cells (Gujda´r
et al., 2004). It is thus reasonable to assume that PKC-bII
suppresses HGF-induced cell migration in melanocytes by
inducing serine/threonine phosphorylation of Gab1 to pre-
vent its association with PI3K through tyrosine phosphoryla-
tion (Figure 7). The negative regulation of PI3K by PKC has
also been reported by Wen et al. (2002). Conversely, it seems
that the introduction of PKC-bII into melanoma cells did not
affect the tyrosine phosphorylation of Gab1 in resting
conditions (Figure 5b). This is possibly either because
PKCbII-induced serine/threonine phosphorylation of Gab1
in resting conditions is not sufficient to induce detectable
suppression of Gab1 tyrosine phosphorylation or because
PKCbII-induced serine/threonine phosphorylation only inhi-
bits HGF-induced Gab1 tyrosine phosphorylation. The loss of
PKC-bII could be one of the steps that melanoma cells gain
invasive and metastatic potential. In contrast, PKC-a facilitates
tyrosine phosphorylation of Gab1 in vascular smooth muscle
cells (Saito et al., 2002). Further studies are required to clarify
the role of each PKC isoform in the regulation of Gab1.
HGF activates multiple signaling pathways including PI3K
and ERK, and it has been demonstrated that PI3K plays a
crucial role in cellular transformation (Katso et al., 2001). In
melanoma cells, PI3K has been implicated in invasion
(Stewart et al., 2002; Nakahara et al., 2003), cell migration
(Metzner et al., 1996; Neudauer and McCarthy, 2003), and
expression of the invasion/metastasis-related melanoma cell
adhesion molecule (Li et al., 2003). In fact, transgenic mice
ubiquitously expressing HGF develop melanomas with a high
invasive and metastatic potential (Takayama et al., 1997;
Otsuka et al., 1998). Alternatively, ERK is constitutively
activated in these cells by both mutation of its upstream
protein kinase and autocrine growth factor stimulation
(Satyamoorthy et al., 2003). It has been suggested that this
protein kinase is important in the oncogenesis of melanoma
(Smalley, 2003). In this study, high ERK activity under resting
conditions and its slight enhancement by HGF were observed
in the melanoma cell lines employed. Therefore, it is
attractive to assume that HGF has a dual function in
melanoma tumor progression by activating ERK and PI3K:
continuous ERK activation induces the transformation of
melanocytes to melanoma cells, and PI3K activation con-
tributes to the enhancement of the invasive potential of
melanoma cells.
Nakamura et al. (1997) has proposed that the invasive and
metastatic potential of several types of carcinoma cells are
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regulated through interactions with the host stroma cells, for
example, tumor–stroma interactions. They showed that
growth factors derived from carcinoma cells such as basic
fibroblast growth factor, IL-1, and platelet-derived growth
factor induce HGF production in stromal fibroblasts, which,
in turn, leads to increased invasive potential in carcinoma
cells. It is well known that melanoma cells produce a variety
of growth factors including basic fibroblast growth factor,
IL-1, and platelet-derived growth factor (Herlyn et al., 1987).
Therefore, it is possible that growth factors generated by
melanoma cells promote HGF production in stromal cells,
such as skin fibroblasts, to enhance the invasive potential of
these cells in a paracrine fashion in vivo. Further analysis of
the detailed mechanisms of positive and negative regulation
of the HGF signaling pathway will contribute to a better
understanding for melanoma metastasis.
MATERIALS AND METHODS
Adenovirus vectors
The recombinant adenovirus vectors encoding PKC-a, PKC-bII, the
kinase-negative mutant of PKC-bII in which Lys-371 in the ATP
binding site is replaced by Arg (KN-PKCb), and the dominant-
negative mutant of class IA PI3K (Dp85) were prepared, as described
previously (Oka et al., 2000, 2002). They were designated AxPKC-a,
-b, AxKN-PKCb, and AxDp85, respectively. The adenovirus carrying
the b-galactosidase gene (LacZ) from Escherichia coli designated
AxLacZ was used as a control virus.
Cells and cell culture
Human normal melanocytes isolated from neonatal foreskin were
obtained from Cascade Biologics (Portland, OR) and maintained in
medium 154 supplemented with 0.5% fetal bovine serum, 0.4%
bovine pituitary extract, 3 ng/ml recombinant human basic fibroblast
growth factor, 0.5 mM hydrocortisone, 5mg/ml bovine insulin, 5mg/ml
human transferrin, 3 mg/ml heparin, 100 U/ml penicillin, 100mg/ml
streptomycin, and 250 ng/ml fungizone in a humidified atmosphere
containing 5% CO2 at 371C, as described (Oka et al., 2002). Three
human melanoma cell lines, MeWo, HM3KO, and HMV-I, were
used in this study. MeWo was obtained from the Japanese Cancer
Research Resources Bank (Tokyo, Japan). HM3KO was established
as described previously (Sasase et al., 1989). HMV-I was obtained
from the Riken Cell Bank at the Institute of Physical and Chemical
Research (Tsukuba, Japan). Melanoma cells were cultured in Eagle’s
minimal essential medium containing 10% fetal calf serum, 100 U/ml
penicillin, 100mg/ml streptomycin, and 250 ng/ml fungizone in the
presence of 5% CO2 at 371C. Melanocytes and melanoma cells were
deprived of growth factors and serum for 24 hours, and then treated
with HGF (Sigma, St Louis, MO) or insulin. Where indicated,
melanoma cells were infected with 20 plaque-forming units/cell of
each adenovirus vector for 24 hours (Oka et al., 2000, 2002), and
then subjected to serum starvation and cell stimulation.
Immunoprecipitation and immunoblot analysis
The cell lysates were prepared as described previously (Oka et al.,
2002) and incubated for 3 hours at 0–41C with antibodies against
phosphotyrosine (PY20, Transduction Laboratories, Lexington, KY)
or Gab1 (Upstate Biotechnology, Lake Placid, NY). Then, Protein
A-Sepharose (Pharmacia Biotech, Uppsala, Sweden) was added to
the mixture and incubated for 1 hour at 0–41C with constant mixing.
The immunoprecipitates were separated by SDS-PAGE and trans-
ferred onto an Immobilon P membrane (Millipore, Bedford, MA). For
the detection of ERK, phosphorylated ERK, and PKC isoforms, the
lysates were directly applied to SDS-PAGE. Immunoblot analysis
was carried out using antibodies against c-Met (Santa Cruz
Biotechnology, Santa Cruz, CA), ERK (Cell Signaling Technology,
Beverly, MA), phospho-ERK (Cell Signaling Technology), Gab1,
PKC-a (Santa Cruz Biotechnology), PKC-b (Transduction Labora-
tories), and the p85 subunit of PI3K (Santa Cruz Biotechnology) as
the primary antibodies. Alkaline phosphatase-conjugated anti-rabbit
antibody (for c-Met, ERK, and phospho-ERK; Promega, Madison,
WI), peroxidase-conjugated anti-mouse (for PKC-a, -b, p85, and
PY20), and anti-rabbit (for Gab1) antibodies (Amersham Bioscience,
Piscataway, NJ) were employed as the secondary antibodies. The
color reaction for alkaline phosphatase was carried out using
5-bromo-4-chloro-3-indoyl-phosphate and nitro blue tetrazolium
(Sigma) as substrates. The oxidative reaction by peroxidase was
detected using enhanced chemiluminescence western blotting
detection reagents (Amersham Bioscience). Where indicated, the
immunoprecipitates were treated with calf intestine alkaline
phosphatase (Takara, Tokyo, Japan) for 2 hours at 371C in 50 mM
Tris–HCl (pH 9.0) containing 1 mM MgCl2.
PI3K assay
The PI3K activity was measured as described previously (Endemann
et al., 1990). Briefly, the lysates from 1 106 cells were subjected to
immunoprecipitation with PY20, and the immunoprecipitates were
incubated with 0.2 mg/ml PI for 5 minutes at room temperature in a
reaction mixture containing 20 mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) (pH 7.1), 50 mM MgCl2, and 250 mM
[g-32P]ATP. The lipids extracted from the mixture were applied to
thin layer chromatography, and the generation of the radioactive
PI3-phosphate [PI(3)P] was detected and quantitated using Bioima-
ging Analyzer (BAS 2000, Fuji Film, Tokyo, Japan).
Invasion assay
The in vitro invasion of melanoma cells was evaluated employing a
cell invasion assay kit (Chemicon International, Temacula, CA)
essentially as described previously (Terranova et al., 1986). Briefly,
melanoma cells suspended in serum-free Eagle’s minimal essential
medium (1 106 cells/ml) were seeded in the upper part of the
invasion chamber, and the cell numbers that migrated through the
polycarbonate membrane to the lower part of the chamber filled
with medium containing 100 ng/ml HGF were counted after
cultivation for 48 hours. Each assay was performed in triplicate.
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